Fluidigm's Polaris

Fluidigm said this week that it will provide attendees of the Advances in Genome Biology and Technology meeting a first look at the firm's new Polaris single-cell research system. Polaris integrates cell selection, isolation, dose, culture, and molecular preparation into a single workflow. According to the firm, it will enable researchers to directly correlate gene expression with environmental conditions and phenotypic information. Fluidigm plans to begin shipping the new system mid-year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.